Analysts/Institutional Investor Meet/Con. Call Updates Laurus Labs Limited has informed the Exchange about Transcript · 2023-07-27
Can you just walk us through, you know you called out the reasons for why margins fell so much this quarter, can you I mean without specific numbers can you just walk us to whatever levers for margin can improve Q2 onwards?
And what drives the improvement as we go forward, because I mean again next quarter if you look at next quarter if ARV formulation revenue s pick up and CDMO I mean you are saying improvement is really second half onwards. So, I mean the mix is again adverse right, there has been more ARV versus CDMO in the next quarter, so what is the confidence that margin will improve from where we are today. So, what gives you confidence that margins will improve from where we are today?